Otitis Media - Pipeline Review, H2 2019

Publisher Name :
Date: 23-Sep-2019
No. of pages: 71
Inquire Before Buying

Otitis Media - Pipeline Review, H2 2019

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Otitis Media - Pipeline Review, H2 2019, provides an overview of the Otitis Media (Ear Nose Throat Disorders) pipeline landscape.

Otitis media (OM) is any inflammation of the middle ear, the air-filled space behind the eardrum that contains the tiny vibrating bones of the ear. Symptoms include ear pain, difficulty sleeping, loss of balance, fever, headache and loss of appetite. Risk factors include age, seasonal factors and exposure to tobacco smoke or high levels of air pollution. Treatment includes antibiotics and antipyrine.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Otitis Media - Pipeline Review, H2 2019, provides comprehensive information on the therapeutics under development for Otitis Media (Ear Nose Throat Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Otitis Media (Ear Nose Throat Disorders) pipeline guide also reviews of key players involved in therapeutic development for Otitis Media and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 1, 3, 1, 7 and 1 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively.

Otitis Media (Ear Nose Throat Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Otitis Media (Ear Nose Throat Disorders).

- The pipeline guide reviews pipeline therapeutics for Otitis Media (Ear Nose Throat Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Otitis Media (Ear Nose Throat Disorders) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Otitis Media (Ear Nose Throat Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews latest news related to pipeline therapeutics for Otitis Media (Ear Nose Throat Disorders)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Otitis Media (Ear Nose Throat Disorders).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Otitis Media (Ear Nose Throat Disorders) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Otitis Media - Pipeline Review, H2 2019

Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Otitis Media - Overview
Otitis Media - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Otitis Media - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Otitis Media - Companies Involved in Therapeutics Development
Lee's Pharmaceutical Holdings Ltd
Madam Therapeutics BV
Merck & Co Inc
MerLion Pharmaceuticals Pte Ltd
Novus Therapeutics Inc
Yuhan Corp
Otitis Media - Drug Profiles
(cholesteryl palmitate + colfosceril palmitate) - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(dexamethasone + piperacillin + tazobactam) - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
aspoxicillin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Drugs for Otitis Media - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ENT-103 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
finafloxacin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
OR-404IT - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
pazufloxacin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PCL-1440 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
pneumococcal (13-valent) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
pneumococcal (23-valent) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Recombinant Peptide to Inhibit DNA for Otitis Media and Haemophilus Influenzae Infections - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules for Otitis Media - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
solithromycin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
tebipenem pivoxil - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Otitis Media - Dormant Projects
Otitis Media - Product Development Milestones
Featured News & Press Releases
Jun 10, 2019: Novus Therapeutics to present OP0201 data at the 20th international symposium on recent advances in otitis media
Apr 23, 2019: Novus' Phase I trials of otitis media drug meet primary objective
Feb 20, 2019: Novus Therapeutics begins dosing in otitis media drug trial
Feb 11, 2019: Novus Therapeutics doses first subjects in phase 1 pharmacodynamics study of OP0201
Jan 30, 2019: Novus Therapeutics Advances OP0201 Development Program Across Several Clinical Trials
Jan 10, 2019: Novus doses first patient in Phase I trial of OP0201
Dec 04, 2018: Novus Therapeutics announces formation of Scientific Advisory Board
Nov 28, 2018: Novus Therapeutics doses first subject in Phase I trial of OP0201
Jun 19, 2018: Novus Therapeutics Receives FDA Guidance at Type C Meeting for OP-02 in the Treatment and Prevention of Otitis Media
Jun 02, 2017: Eight Presentations at ASM Microbe Include Late Breaker From Cempra's Phase 3 Fusidic Acid Study and Solithromycin Data on Gonorrhea and Otitis Media
Oct 29, 2012: Study Suggests New Way to Prevent Recurrent Ear Infections
Apr 18, 2012: MerLion Initiates Phase III Clinical Program To Evaluate Finafloxacin For Treatment Of Acute Otitis Media
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Otitis Media, H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products under Development by Universities/Institutes, H2 2019
Products under Development by Companies, H2 2019
Products under Development by Universities/Institutes, H2 2019
Number of Products by Stage and Target, H2 2019
Number of Products by Stage and Mechanism of Action, H2 2019
Number of Products by Stage and Route of Administration, H2 2019
Number of Products by Stage and Molecule Type, H2 2019
Otitis Media - Pipeline by Lee's Pharmaceutical Holdings Ltd, H2 2019
Otitis Media - Pipeline by Madam Therapeutics BV, H2 2019
Otitis Media - Pipeline by Merck & Co Inc, H2 2019
Otitis Media - Pipeline by MerLion Pharmaceuticals Pte Ltd, H2 2019
Otitis Media - Pipeline by Novus Therapeutics Inc, H2 2019
Otitis Media - Pipeline by Yuhan Corp, H2 2019
Otitis Media - Dormant Projects, H2 2019

List of Figures
Number of Products under Development for Otitis Media, H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products by Targets, H2 2019
Number of Products by Stage and Targets, H2 2019
Number of Products by Mechanism of Actions, H2 2019
Number of Products by Stage and Mechanism of Actions, H2 2019
Number of Products by Routes of Administration, H2 2019
Number of Products by Stage and Routes of Administration, H2 2019
Number of Products by Molecule Types, H2 2019
Number of Products by Stage and Molecule Types, H2 2019
  • Global Cochlear Implant (CI) System Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 86
    A Cochlear Implant (CI) System is a small, complex electronic device that can help to provide a sense of sound to a person who is profoundly deaf or severely hard-of-hearing. The implant consists of an external portion that sits behind The ear and a second portion that is surgically placed under The skin. An implant does not restore normal hearing. Instead, it can give a deaf person a useful representation of sounds in The environment and help him or her to understand speech. ......
  • Global Ear Syringe Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 88
    Ear Syringe is a simple pump consisting of a plunger that fits tightly in a tube. The plunger can be pulled and pushed along inside a cylindrical tube (called a barrel), allowing The Ear Syringe to take in and expel a liquid or gas through an orifice at The open end of The tube. Ear Syringe are often used to administer injections, insert intravenous drugs into The bloodstream, apply compounds such as glue or lubricant, and measure liquids. Ear Ear Syringe helps remove stubborn ear wax buil......
  • Global Diagnostic Audiometer Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 98
    According to our LPI (LP Information) latest study, the global Diagnostic Audiometer market size was valued at US$ 172.7 million in 2023. With growing demand in downstream market, the Diagnostic Audiometer is forecast to a readjusted size of US$ 246 million by 2030 with a CAGR of 5.2% during review period. The research report highlights the growth potential of the global Diagnostic Audiometer market. Diagnostic Audiometer are expected to show stable growth in the future market. However, ......
  • Global Diagnostic Tympanometers Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 92
    The Diagnostic Tympanometers market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diagnostic Tympanometers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provi......
  • Global ENT Chairs Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 107
    According to our LPI (LP Information) latest study, the global ENT Chairs market size was valued at US$ 305.2 million in 2023. With growing demand in downstream market, the ENT Chairs is forecast to a readjusted size of US$ 533.3 million by 2030 with a CAGR of 8.3% during review period. The research report highlights the growth potential of the global ENT Chairs market. ENT Chairs are expected to show stable growth in the future market. However, product differentiation, reducing costs, a......
  • Global Hearing Healthcare Devices Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 87
    According to our LPI (LP Information) latest study, the global Hearing Healthcare Devices market size was valued at US$ 8267.3 million in 2023. With growing demand in downstream market, the Hearing Healthcare Devices is forecast to a readjusted size of US$ 10250 million by 2030 with a CAGR of 3.1% during review period. The research report highlights the growth potential of the global Hearing Healthcare Devices market. Hearing Healthcare Devices are expected to show stable growth in the f......
  • Global ENT Surgical Devices Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 102
    According to our LPI (LP Information) latest study, the global ENT Surgical Devices market size was valued at US$ 2900.9 million in 2023. With growing demand in downstream market, the ENT Surgical Devices is forecast to a readjusted size of US$ 4518.5 million by 2030 with a CAGR of 6.5% during review period. The research report highlights the growth potential of the global ENT Surgical Devices market. ENT Surgical Devices are expected to show stable growth in the future market. However, ......
  • Global Cochlear Implant (CI) System Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Cochlear Implant (CI) System market size was valued at US$ 1904.4 million in 2023. With growing demand in downstream market, the Cochlear Implant (CI) System is forecast to a readjusted size of US$ 3557.1 million by 2030 with a CAGR of 9.3% during review period. The research report highlights the growth potential of the global Cochlear Implant (CI) System market. Cochlear Implant (CI) System are expected to show stable growth......
  • Global Ear-Based Hearing Aids Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114
    According to our LPI (LP Information) latest study, the global Ear-Based Hearing Aids market size was valued at US$ 9011.7 million in 2023. With growing demand in downstream market, the Ear-Based Hearing Aids is forecast to a readjusted size of US$ 14130 million by 2030 with a CAGR of 6.6% during review period. The research report highlights the growth potential of the global Ear-Based Hearing Aids market. Ear-Based Hearing Aids are expected to show stable growth in the future market. Ho......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs